Table 1.
Characteristics of studied groups.
| Variable | Psoriatic patients | Control group | ||||||
|---|---|---|---|---|---|---|---|---|
| Min | Max | M | SD | Min | Max | M | SD | |
| Age (years) | 26 | 76 | 50.14 | 14.51 | 27 | 75 | 46.85 | 13.44 |
| BMI | 18.8 | 46.1 | 27.32 | 5.30 | 20.68 | 30.19 | 24.81 | 3.09 |
| Age of psoriasis onset (years) | 1 | 71 | 29.29 | 17.37 | ||||
| Duration of psoriasis (years) | 5 | 44 | 20.86 | 12.82 | ||||
| PASI | 10 | 47 | 24.52 | 10.36 | ||||
| PGA | 3 | 5 | 3.76 | 0.89 | ||||
| BSA (%) | 13 | 90 | 42.6 | 25.29 | ||||
| NAPSI | 0 | 80 | 23.43 | 19.82 | ||||
| DLQI | 6 | 30 | 18.62 | 7.76 | ||||
| Il-17 serum concentration | 0.54 | 11.23 | 4.24 | 3.69 | 1.21 | 6.23 | 3.06 | 1.19 |
| IL-17 scale concentration | 14.74 | 181.57 | 68.32 | 51.68 | ||||